{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:11:57Z","timestamp":1788199917829,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4010-7","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T15:02:46Z","timestamp":1556809366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Nayuta","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-7986","authenticated-orcid":false,"given":"Yutaka","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugumi","family":"Horikiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"4010_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","volume":"378","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378:57\u201372.","journal-title":"Lancet"},{"key":"4010_CR2","doi-asserted-by":"publisher","unstructured":"Costa-Veiga A, Briz T, Nunes C. Unsuccessful treatment in pulmonary tuberculosis: factors and a consequent predictive model. Eur J Pub Health. 2017. \n                    https:\/\/doi.org\/10.1093\/eurpub\/ckx136\n                    \n                  .","DOI":"10.1093\/eurpub\/ckx136"},{"key":"4010_CR3","doi-asserted-by":"crossref","unstructured":"Lin CH, Lin CJ, Kuo YW, Wang JY, Hsu CL, Chen JM, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis. 2014;3:14:5.","DOI":"10.1186\/1471-2334-14-5"},{"key":"4010_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1086\/338784","volume":"34","author":"KK Oursler","year":"2002","unstructured":"Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002;34:752\u20139.","journal-title":"Clin Infect Dis"},{"key":"4010_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","volume":"90","author":"K Romanowski","year":"2016","unstructured":"Romanowski K, Clark EG, Levin A, Cook VJ, Johnston JC. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int. 2016;90:34\u201340.","journal-title":"Kidney Int"},{"key":"4010_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.5588\/ijtld.15.0081","volume":"19","author":"K Al-Efraij","year":"2015","unstructured":"Al-Efraij K, Mota L, Lunny C, Schachter M, Cook V, Johnston J. Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2015;19:1493\u20139.","journal-title":"Int J Tuberc Lung Dis."},{"key":"4010_CR7","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s12010-014-1217-3","volume":"174","author":"P Kumari","year":"2014","unstructured":"Kumari P, Meena LS. Factors affecting susceptibility to Mycobacterium tuberculosis: a close view of immunological defence mechanism. Appl Biochem Biotechnol. 2014;174:2663\u201373.","journal-title":"Appl Biochem Biotechnol"},{"key":"4010_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","volume":"16","author":"MM Hussein","year":"2003","unstructured":"Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16:38\u201344.","journal-title":"Semin Dial"},{"key":"4010_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5588\/ijtld.13.0726","volume":"18","author":"P Baghaei","year":"2014","unstructured":"Baghaei P, Marjani M, Tabarsi P, Moniri A, Rashidfarrokhi F, Ahmadi F, et al. Impact of chronic renal failure on anti-tuberculosis treatment outcomes. Int J Tuberc Lung Dis. 2014;18:352\u20136.","journal-title":"Int J Tuberc Lung Dis."},{"key":"4010_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2169\/internalmedicine.48.2660","volume":"48","author":"H Nakamura","year":"2009","unstructured":"Nakamura H, Tateyama M, Tasato D, Teruya H, Chibana K, Tamaki Y, et al. Active tuberculosis in patients undergoing hemodialysis for end-stage renal disease: a 9-year retrospective analysis in a single center. Intern Med. 2009;48:2061\u20137.","journal-title":"Intern Med"},{"key":"4010_CR11","first-page":"92","volume":"8","author":"HC Fang","year":"2004","unstructured":"Fang HC, Lee PT, Chen CL, Wu MJ, Chou KJ, Chung HM. Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis. 2004;8:92\u20137.","journal-title":"Int J Tuberc Lung Dis."},{"key":"4010_CR12","first-page":"134","volume":"54","author":"H Taskapan","year":"2000","unstructured":"Taskapan H, Utas C, Oymak FS, G\u00fclmez I, Ozesmi M. The outcome of tuberculosis in patients on chronic hemodialysis. Clin Nephrol. 2000;54:134\u20137.","journal-title":"Clin Nephrol"},{"key":"4010_CR13","volume-title":"Treatment of Tuberculosis: Guidelines 4th ed. (WHO\/HTM\/TB\/2009.420)","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Treatment of Tuberculosis: Guidelines 4th ed. (WHO\/HTM\/TB\/2009.420). Geneva: WHO; 2010."},{"key":"4010_CR14","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147\u201395.","journal-title":"Clin Infect Dis"},{"key":"4010_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/thx.2010.144295","volume":"65","author":"H Milburn","year":"2010","unstructured":"British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010;65:557\u201370.","journal-title":"Thorax"},{"key":"4010_CR16","first-page":"683","volume":"89","author":"The Treatment Committee of the Japanese Society for Tuberculosis","year":"2014","unstructured":"The Treatment Committee of the Japanese Society for Tuberculosis. Review of \u201cSTANDARDS for tuberculosis care\u201d\u2014 2014. Kekkaku. 2014;89:683\u201390 (in Japanese).","journal-title":"Kekkaku."},{"key":"4010_CR17","first-page":"53","volume":"61","author":"The Treatment Committee of the Japanese Society for Tuberculosis","year":"1986","unstructured":"The Treatment Committee of the Japanese Society for Tuberculosis. Views on the use of anti-tuberculosis drugs in patients with liver or renal insufficiency. Kekkaku. 1986;61:53\u20135 (in Japanese).","journal-title":"Kekkaku."},{"key":"4010_CR18","volume-title":"Notification of the new criteria for admission and discharge for active TB (Law No. 0907001)","author":"Ministry of Health, Labour and Welfare of Japan","year":"2007","unstructured":"Ministry of Health, Labour and Welfare of Japan. Notification of the new criteria for admission and discharge for active TB (Law No. 0907001). 2007. (in Japanese)."},{"key":"4010_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE. Levin a; kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330.","journal-title":"Ann Intern Med"},{"key":"4010_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"4010_CR21","first-page":"697","volume":"72","author":"Japanese Society for Tuberculosis","year":"1997","unstructured":"Japanese Society for Tuberculosis. Desensitization therapy of antituberculous drugs. Kekkaku. 1997;72:697\u2013700 (in Japanese).","journal-title":"Kekkaku."},{"key":"4010_CR22","unstructured":"World Health Organization. The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. \n                    http:\/\/www.who.int\/tb\/post2015_strategy\/en\/\n                    \n                  . Accessed 23 Sept 2018."},{"key":"4010_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5588\/ijtld.14.0333","volume":"19","author":"H Yamana","year":"2015","unstructured":"Yamana H, Matsui H, Fushimi K, Yasunaga H. Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study. Int J Tuberc Lung Dis. 2015;19:120\u20136.","journal-title":"Int J Tuberc Lung Dis."},{"key":"4010_CR24","first-page":"79","volume":"14","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Lee CH, Shin S, Lee JH, Kim YW, Chung HS, et al. The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010;14:79\u201385.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4010_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1378\/chest.126.4.1079","volume":"126","author":"NN Hansel","year":"2004","unstructured":"Hansel NN, Merriman B, Haponik EF, Diette GB. Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality. Chest. 2004;126:1079\u201386.","journal-title":"Chest"},{"key":"4010_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1164\/ajrccm.165.7.2107040","volume":"165","author":"C Greenaway","year":"2002","unstructured":"Greenaway C, Menzies D, Fanning A, Grewal R, Yuan L, FitzGerald JM, et al. Delay in diagnosis among hospitalized patients with active tuberculosis\u2013predictors and outcomes. Am J Respir Crit Care Med. 2002;165:927\u201333.","journal-title":"Am J Respir Crit Care Med"},{"key":"4010_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1378\/chest.114.5.1244","volume":"114","author":"VK Rao","year":"1998","unstructured":"Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998;114:1244\u201352.","journal-title":"Chest"},{"key":"4010_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/jama.1997.03550100064040","volume":"278","author":"L Singleton","year":"1997","unstructured":"Singleton L, Turner M, Haskal R, Etkind S, Tricarico M, Nardell E. Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit. JAMA. 1997;278:838\u201342.","journal-title":"JAMA"},{"key":"4010_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/thx.2006.058867","volume":"61","author":"RA Breen","year":"2006","unstructured":"Breen RA, Miller RF, Gorsuch T, Smith CJ, Schwenk A, Holmes W, et al. Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax. 2006;61:791\u20134.","journal-title":"Thorax"},{"key":"4010_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1086\/422645","volume":"39","author":"R van Hest","year":"2004","unstructured":"van Hest R, Baars H, Kik S, van Gerven P, Trompenaars MC, Kalisvaart N, et al. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clin Infect Dis. 2004;39:488\u201396.","journal-title":"Clin Infect Dis"},{"key":"4010_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1164\/rccm.2108091","volume":"166","author":"SK Sharma","year":"2002","unstructured":"Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med. 2002;166:916\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"4010_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0962-8479(96)90073-8","volume":"77","author":"LP Ormerod","year":"1996","unstructured":"Ormerod LP, Horsfield N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis. 1996;77:37\u201342.","journal-title":"Tuber Lung Dis"},{"key":"4010_CR33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","volume":"167","author":"D Yee","year":"2003","unstructured":"Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4010_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159827","volume":"11","author":"HW Lee","year":"2016","unstructured":"Lee HW, Lee JK, Kim E, Yim JJ, Lee CH. The effectiveness and safety of fluoroquinolone-containing regimen as a first-line treatment for drug-sensitive pulmonary tuberculosis: a systematic review and meta-analysis. PLoS One. 2016;11:e0159827.","journal-title":"PLoS One"},{"key":"4010_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/clpt.1993.198","volume":"54","author":"YG Kim","year":"1993","unstructured":"Kim YG, Shin JG, Shin SG, Jang IJ, Kim S, Lee JS, et al. Decreased acetylation of isoniazid in chronic renal failure. Clin Pharmacol Ther. 1993;54:612\u201320.","journal-title":"Clin Pharmacol Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4010-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T23:10:18Z","timestamp":1588288218000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4010"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4010-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Jikei University School of Medicine [No. 27\u2013031(7938)]. Informed consent was waived by the ethics committee because we retrospectively collected data without using identifying information or applying any interventions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"374"}}